Increased age is a significant risk factor for the development of dementia, predominately Alzheimer disease (AD). Since the fastest growing population sector in the United States is individuals over the age of 85 years, a surge in cases of dementia is expected. The inherent features of dementia mean those affected will eventually be incapacitated and require a high level of medical care. The majority of individuals dying from the complications of dementia will be under the care of a physician. However, dementia is a significant morbidity and demented patients are at risk from dying of non-natural causes (e.g., neglect/abuse or accidental injury) that necessitates the medical examiner/coroner (ME/C) to determine if the individual was incapacitated by a neurodegenerative process. The definitive diagnosis of a specific type of dementia requires a postmortem neuropathological examination. This paper provides a concise description of and a practical neuropathological algorithmic approach to the diagnosis of the most common neurodegenerative diseases.
TrojanowskiJ.Q., ArnoldS.E., KarlawishJ.H.Design of comprehensive Alzheimer's disease centers to address unmet national needs. Alzheimers Dement.2010 Mar; 6(2): 150–5.
2.
HebertL.E., BeckettL.A., ScherrP.A., EvansD.A.Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord.2001 Oct-Dec; 15(4): 169–73.
3.
MininoA., JiaquanX., KochanekK.D.Deaths: preliminary data for 2008. Natl Vital Stat Rep.2010 Dec; 59(2): 1–52.
4.
ArrighiH.M., NeumannP.J., LieberburgI.M., TownsendR.J.Lethality of Alzheimer disease and its impact on nursing home placement. Alzheimer Dis Assoc Disord.2010 Jan-Mar; 24(1): 90–5.
5.
United States. Government Accountability Office. Nursing home deaths: Arkansas coroner referrals confirm weaknesses in state and federal oversight of quality of care. Washington, DC: GAO; 2004. 70 p.
6.
PanulaJ., PihlajamakiH., MattilaV.M.Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study. BMC Musculoskelet Disord.2011 May 20; 12: 105.
7.
GoldmanJ.S., FarmerJ.M., Van DeerlinV.M.Frontotemporal dementia: genetics and genetic counseling dilemmas. Neurologist.2004 Sep; 10(5): 227–34.
8.
PubMed Health [Internet].Bethesda, MD: National Center for Biotechnology Information, U.S. National Library of Medicine; c2012. Dementia; 2011 Sep 26 [cited 2012 Jan 26]; Available from: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001748/.
9.
PubMed Health [Internet].Bethesda, MD: National Center for Biotechnology Information, U.S. National Library of Medicine; c2012. Delirium; 2010 Feb 6 [cited 2012 Jan 26]; Available from: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001749/.
10.
McKeeA.C., CantuR.C., NowinskiC.J.Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol.2009 Jul; 68(7): 709–35.
MontineT.J., PhelpsC.H., BeachT.G.National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol.2012 Jan; 123(1): 1–11.
13.
DicksonD.W.Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases. Acta Neuropathol.2005 Jan; 109(1): 14–24.
14.
BraakH., BraakE.Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol.1991; 82(4): 239–59.
15.
BraakH., Del TrediciK., RübU.Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging.2003 Mar-Apr; 24(2): 197–211.
16.
KosakaK., YoshimuraM., IkedaK., BudkaH.Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a new disease?Clin Neuropathol.1984 Sep-Oct; 3(5): 185–92.
17.
CrainB.J.Creutzfeldt-Jakob Disease: Safety tips for anatomic studies of possible CJD. CAP Today.1996 Jan; 10(1): 56.
18.
McKeithI.G., DicksonD.W., LoweJ.Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology.2005 Dec 27; 65(12): 1863–72.
19.
CairnsN.J., BigioE.H., MackenzieI.R.Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol.2007 Jul; 114(1): 5–22.
20.
MirraS.S.The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiol Aging.1997 Jul-Aug; 18(4 Suppl): S91–4.
21.
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging.1997 Jul-Aug; 18(4 Suppl): S1–2.
22.
MirraS.S., HeymanA., McKeelD.The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology.1991 Apr; 41(4): 479–86.
23.
LippaC.F., DudaJ.E., GrossmanM.DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology.2007 Mar 13; 68(11): 812–9.
